Areteia Secures $75M for Asthma Drug Expansion
Key Highlights $75 million in additional Series A financing brings total to $425 million for dexpramipexole’s global Phase III…
Browsing Tag
Marshall Wace
2 posts
Parse Biosciences Secures $50 Million in Series C Financing and Debt Facility to Propel Single Cell Sequencing Innovations
Key Highlights $50 million raised in Series C equity round and debt facility, led by Soleus Capital, with notable…